EnteroMedics Company Profile (NASDAQ:ETRM)

About EnteroMedics (NASDAQ:ETRM)

EnteroMedics logoEnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC therapy, is designed to intermittently block the vagus nerve. The Company's initial product is the Maestro Rechargeable System, which uses VBLOC therapy to limit the expansion of the stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The Company's VBLOC therapy is designed to block the gastrointestinal effects of the vagus nerve by replicating a vagotomy using high-frequency, low-energy electrical impulses to intermittently interrupt naturally occurring neural impulses on the vagus nerve between the brain and the digestive system.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Advanced Medical Equipment & Technology
  • Sub-Industry: Health Care Equipment
  • Symbol: NASDAQ:ETRM
  • CUSIP: 29365M20
  • Web: www.enteromedics.com
Capitalization:
  • Market Cap: $28.84 million
  • Outstanding Shares: 14,565,000
Average Prices:
  • 50 Day Moving Avg: $1.90
  • 200 Day Moving Avg: $3.74
  • 52 Week Range: $1.60 - $30.41
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.20
  • P/E Growth: -5.88
Sales & Book Value:
  • Annual Revenue: $571,759.00
  • Price / Sales: 52.22
  • Book Value: $4.58 per share
  • Price / Book: 0.45
Profitability:
  • EBITDA: ($22,150,000.00)
  • Net Margins: -4,399.48%
  • Return on Equity: -167.73%
  • Return on Assets: -123.00%
Debt:
  • Current Ratio: 2.95%
  • Quick Ratio: 2.63%
Misc:
  • Average Volume: 937,446 shs.
  • Beta: 3.07
  • Short Ratio: 5.33
 

Frequently Asked Questions for EnteroMedics (NASDAQ:ETRM)

What is EnteroMedics' stock symbol?

EnteroMedics trades on the NASDAQ under the ticker symbol "ETRM."

When did EnteroMedics' stock split? How did EnteroMedics' stock split work?

EnteroMedics shares reverse split before market open on Friday, January 8th 2016. The 1-15 reverse split was announced on Wednesday, December 23rd 2015. The number of shares owned by shareholders was adjusted after the market closes on Thursday, January 7th 2016. An investor that had 100 shares of EnteroMedics stock prior to the reverse split would have 7 shares after the split.

How were EnteroMedics' earnings last quarter?

EnteroMedics Inc. (NASDAQ:ETRM) released its quarterly earnings data on Tuesday, August, 8th. The company reported ($0.91) earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of ($1.00) by $0.09. The company had revenue of $0.09 million for the quarter, compared to analysts' expectations of $0.20 million. EnteroMedics had a negative return on equity of 167.73% and a negative net margin of 4,399.48%. View EnteroMedics' Earnings History.

When will EnteroMedics make its next earnings announcement?

EnteroMedics is scheduled to release their next quarterly earnings announcement on Thursday, November, 9th 2017. View Earnings Estimates for EnteroMedics.

Where is EnteroMedics' stock going? Where will EnteroMedics' stock price be in 2017?

1 equities research analysts have issued 12 month price targets for EnteroMedics' stock. Their predictions range from $11.00 to $11.06. On average, they anticipate EnteroMedics' share price to reach $11.03 in the next twelve months. View Analyst Ratings for EnteroMedics.

Who are some of EnteroMedics' key competitors?

Who are EnteroMedics' key executives?

EnteroMedics' management team includes the folowing people:

  • Dan W. Gladney, Chairman of the Board, President, Chief Executive Officer
  • Scott P. Youngstrom, Chief Financial Officer, Chief Compliance Officer
  • Naqeeb Ansari, Senior Vice President - Sales
  • Paul Hickey, Senior Vice President - Marketing and Reimbursement
  • Peter M. Delange, Senior Vice President - Operations and Business Development
  • Adrianus Donders, Senior Vice President - Research and Advanced Development
  • Katherine S. Tweden Ph.D., Senior Vice President - Research
  • Tonya Dowd, Vice President - Reimbursement
  • Gary D. Blackford, Director
  • Lori Courtney McDougal, Director

How do I buy EnteroMedics stock?

Shares of EnteroMedics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is EnteroMedics' stock price today?

One share of EnteroMedics stock can currently be purchased for approximately $2.05.


MarketBeat Community Rating for EnteroMedics (NASDAQ ETRM)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  133 (Vote Outperform)
Underperform Votes:  93 (Vote Underperform)
Total Votes:  226
MarketBeat's community ratings are surveys of what our community members think about EnteroMedics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for EnteroMedics (NASDAQ:ETRM) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $11.03 (438.05% upside)
Consensus Price Target History for EnteroMedics (NASDAQ:ETRM)
Price Target History for EnteroMedics (NASDAQ:ETRM)
Analysts' Ratings History for EnteroMedics (NASDAQ:ETRM)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/25/2017Ladenburg Thalmann Financial ServicesReiterated RatingBuy$11.00LowView Rating Details
1/9/2017S&P Equity ResearchLower Price Target$17.19 -> $11.06N/AView Rating Details
6/9/2016Roth CapitalDowngradeBuy -> Neutral$3.00 -> $3.00N/AView Rating Details
11/10/2015Canaccord GenuityLower Price Target$37.50 -> $15.00N/AView Rating Details
(Data available from 10/21/2015 forward)

Earnings

Earnings History for EnteroMedics (NASDAQ:ETRM)
Earnings by Quarter for EnteroMedics (NASDAQ:ETRM)
Earnings History by Quarter for EnteroMedics (NASDAQ ETRM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2017        
8/8/2017Q2 2017($1.00)($0.91)$0.20 million$0.09 millionViewListenView Earnings Details
5/16/2017Q1 2017($0.63)($1.27)$0.04 millionViewN/AView Earnings Details
3/7/2017Q4 2016($0.44)($2.65)$0.14 millionViewN/AView Earnings Details
11/10/2016Q3 2016($0.50)($0.17)$0.34 million$0.30 millionViewN/AView Earnings Details
8/4/2016Q216($0.75)($0.49)$0.19 million$0.28 millionViewN/AView Earnings Details
2/17/2016Q315($0.90)($0.95)$0.43 million$0.15 millionViewListenView Earnings Details
8/6/2015Q215($0.10)($0.10)$0.06 million$0.08 millionViewN/AView Earnings Details
2/18/2015Q414($0.10)($0.09)ViewN/AView Earnings Details
11/12/2014Q3 14($0.10)($0.08)ViewN/AView Earnings Details
8/7/2014Q2($0.10)($0.11)ViewListenView Earnings Details
4/30/2014Q1 14($0.10)($0.10)ViewN/AView Earnings Details
2/12/2014Q413($0.10)($0.11)ViewN/AView Earnings Details
10/31/2013Q313($0.11)($0.11)ViewN/AView Earnings Details
7/31/2013Q2 2013($0.13)($0.11)ViewN/AView Earnings Details
5/1/2013Q1 2013($0.13)($0.14)$0.10 millionViewN/AView Earnings Details
2/13/2013Q4 2012($0.14)($0.17)$0.36 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for EnteroMedics (NASDAQ:ETRM)
Current Year EPS Consensus Estimate: $-1.4 EPS
Next Year EPS Consensus Estimate: $-0.64 EPS

Dividends

Dividend History for EnteroMedics (NASDAQ:ETRM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for EnteroMedics (NASDAQ:ETRM)
Insider Ownership Percentage: 32.50%
Institutional Ownership Percentage: 0.89%
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Institutional Ownership by Quarter for EnteroMedics (NASDAQ:ETRM)
Insider Trades by Quarter for EnteroMedics (NASDAQ:ETRM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Carl GoldfischerDirectorSell4,668$4.85$22,639.80View SEC Filing  
6/3/2016Peter M DelangeSVPBuy20,000$0.55$11,000.00View SEC Filing  
8/13/2015Mark B KnudsonCEOBuy303,000$0.25$75,750.00View SEC Filing  
6/19/2014Cathy FriedmanDirectorBuy11,800$1.70$20,060.00View SEC Filing  
1/8/2014Luke EvninDirectorSell556,585$2.50$1,391,462.50View SEC Filing  
2/27/2013Anthony P JanszDirectorBuy150,000$0.95$142,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for EnteroMedics (NASDAQ:ETRM)
Latest Headlines for EnteroMedics (NASDAQ:ETRM)
Source:
DateHeadline
finance.yahoo.com logoathenahealth (ATHN) Beats Earnings, Misses Revenues in Q3
finance.yahoo.com - October 20 at 4:42 PM
finance.yahoo.com logoToday's Research Reports on Trending Tickers: EnteroMedics and Ionis Pharmaceuticals
finance.yahoo.com - October 17 at 7:09 PM
prnewswire.com logoEnteroMedics Announces Presentations at ObesityWeek 2017 - PR Newswire (press release)
www.prnewswire.com - October 16 at 6:54 PM
finance.yahoo.com logoEnteroMedics Announces Presentations at ObesityWeek 2017
finance.yahoo.com - October 16 at 6:53 PM
americanbankingnews.com logoContrasting EnteroMedics (ETRM) & Derma Sciences (DSCI)
www.americanbankingnews.com - October 16 at 2:10 AM
prnewswire.com logoEnteroMedics Announces New Employee Inducement Option Grants - PR Newswire (press release)
www.prnewswire.com - October 13 at 12:16 AM
finance.yahoo.com logoEnteroMedics Announces New Employee Inducement Option Grants
finance.yahoo.com - October 12 at 7:16 PM
finance.yahoo.com logoThe Zacks Analyst Blog Highlights: Thermo Fisher Scientific, SeaSpine Holdings and EnteroMedics
finance.yahoo.com - October 9 at 6:44 PM
americanbankingnews.com logoHead-To-Head Analysis: EnteroMedics (ETRM) versus BIOLASE (BLTI)
www.americanbankingnews.com - October 9 at 2:26 AM
finance.yahoo.com logo4 Momentum Stocks That May Survive the Health Policy Mess
finance.yahoo.com - October 6 at 6:55 PM
bizjournals.com logoEnteroMedics to move its headquarters to California after acquisition
www.bizjournals.com - October 4 at 5:13 PM
streetinsider.com logoEnteroMedics (ETRM) Acquires ReShape Medical
www.streetinsider.com - October 4 at 5:13 PM
prnewswire.com logoEnteroMedics Announces Acquisition Of ReShape Medical - PR Newswire (press release)
www.prnewswire.com - October 3 at 7:23 PM
streetinsider.com logoEnteroMedics (ETRM) Acquires ReShape Medical - StreetInsider.com
www.streetinsider.com - October 3 at 7:23 PM
seekingalpha.com logoEnteroMedics buys ReShape Medical; shares ahead 30% premarket - Seeking Alpha
seekingalpha.com - October 3 at 7:23 PM
finance.yahoo.com logoEnteroMedics Announces Acquisition Of ReShape Medical
finance.yahoo.com - October 3 at 7:23 PM
finance.yahoo.com logo[$$] ReShape Owners to Receive Board Seats in EnteroMedics Deal
finance.yahoo.com - October 3 at 7:23 PM
seekingalpha.com logoEnteroMedics buys ReShape Medical; shares ahead 30% premarket
seekingalpha.com - October 3 at 9:43 AM
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Short Interest Down 37.0% in August
www.americanbankingnews.com - September 16 at 1:44 AM
americanbankingnews.com logoComparing EnteroMedics (ETRM) and The Competition
www.americanbankingnews.com - September 13 at 4:26 AM
finance.yahoo.com logoEnteroMedics to Present at the Ladenburg Thalmann 2017 Healthcare Conference
finance.yahoo.com - September 12 at 7:15 PM
finance.yahoo.com logoShould You Buy EnteroMedics Inc (ETRM)?
finance.yahoo.com - September 12 at 12:03 AM
finance.yahoo.com logoEnteroMedics Begins Post-Approval Study for the Treatment of Obesity with vBloc Therapy
finance.yahoo.com - September 5 at 8:05 PM
finance.yahoo.com logoStudy Concludes Vagal Nerve Blocking with EnteroMedics' vBloc Therapy is Cost-Effective
finance.yahoo.com - August 28 at 6:11 PM
finance.yahoo.com logoEnteroMedics, Inc. :ETRM-US: Earnings Analysis: Q2, 2017 By the Numbers : August 24, 2017
finance.yahoo.com - August 24 at 7:30 PM
finance.yahoo.com logoEnteroMedics Announces First Veterans Choice Program vBloc® Implant at MedStar Health in Maryland
finance.yahoo.com - August 21 at 6:00 PM
finance.yahoo.com logoEnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference
finance.yahoo.com - August 16 at 9:35 PM
prnewswire.com logoEnteroMedics Announces Presentations Highlighting vBloc and Gastric Vest at IFSO Annual Conference - PR Newswire (press release)
www.prnewswire.com - August 16 at 4:33 PM
streetinsider.com logoEnteroMedics (ETRM) Prices $20M Public Offering of Preferred Stock, Warrants
www.streetinsider.com - August 12 at 4:55 AM
benzinga.com logoMid-Afternoon Market Update: Luxoft Drops On Disappointing Q1 Results; DryShips Shares Surge - Benzinga
www.benzinga.com - August 11 at 11:55 PM
seekingalpha.com logoEnteroMedics readies equity offering; shares down 29% premarket - Seeking Alpha
seekingalpha.com - August 11 at 11:54 PM
finance.yahoo.com logoEnteroMedics Announces Pricing of $20 Million Underwritten Public Offering
finance.yahoo.com - August 11 at 6:53 PM
finance.yahoo.com logoEnteroMedics Announces Proposed Underwritten Public Offering
finance.yahoo.com - August 10 at 7:46 PM
seekingalpha.com logoEnteroMedics' (ETRM) CEO Dan Gladney on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 11:37 PM
finance.yahoo.com logoEdited Transcript of ETRM earnings conference call or presentation 8-Aug-17 3:30pm GMT
finance.yahoo.com - August 9 at 11:36 PM
finance.yahoo.com logoEnteroMedics Announces Second Quarter 2017 Financial Results
finance.yahoo.com - August 8 at 6:11 PM
finance.yahoo.com logoInvestor Network: EnteroMedics Inc. to Host Earnings Call
finance.yahoo.com - August 8 at 6:11 PM
finance.yahoo.com logoEnteroMedics reports 2Q loss
finance.yahoo.com - August 8 at 6:11 PM
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Issues Earnings Results
www.americanbankingnews.com - August 8 at 12:46 PM
americanbankingnews.com logoEnteroMedics (NASDAQ:ETRM) and Synergetics USA (SURG) Head to Head Analysis
www.americanbankingnews.com - August 7 at 12:12 PM
americanbankingnews.com logoEnteroMedics Inc. (ETRM) Set to Announce Earnings on Tuesday
www.americanbankingnews.com - August 3 at 10:58 AM
finance.yahoo.com logoEnteroMedics To Discuss Business Strategy And Financial Results For The Second Quarter Of 2017
finance.yahoo.com - August 2 at 7:18 PM
benzinga.com logo22 Stocks Moving In Monday's Pre-Market Session | Benzinga - Benzinga
www.benzinga.com - August 1 at 7:03 PM
finance.yahoo.com logoEnteroMedics Receives Approval for Gastric Vest System Clinical Study in Spain
finance.yahoo.com - July 31 at 6:08 PM
benzinga.com logo18 Biggest Mid-Day Gainers For Wednesday | Benzinga - Benzinga
www.benzinga.com - July 26 at 7:02 PM
nasdaq.com logoMid-Morning Market Update: Markets Open Higher; Ford Profit Beats ... - Nasdaq
www.nasdaq.com - July 26 at 7:02 PM
streetinsider.com logoEnteroMedics (ETRM) Reports First Veterans Choice Program vBloc Implant for Obesity at Methodist Dallas Medical Center (Earlier)
www.streetinsider.com - July 25 at 11:45 PM
streetinsider.com logoEnteroMedics (ETRM) Reports First Veterans Choice Program vBloc Implant for Obesity at Methodist Dallas Medical ... - StreetInsider.com
www.streetinsider.com - July 25 at 6:43 PM
streetinsider.com logoEnteroMedics (ETRM) Enters Collaboration Agreement with Galvani Bioelectronics - StreetInsider.com
www.streetinsider.com - July 25 at 6:43 PM
finance.yahoo.com logoEnteroMedics Announces First Veterans Choice Program vBloc® Implant for Obesity at Methodist Dallas Medical Center
finance.yahoo.com - July 25 at 6:43 PM

Social

Chart

EnteroMedics (ETRM) Chart for Saturday, October, 21, 2017

This page was last updated on 10/21/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.